StockWatch
·
HomeLiveReports
Biotechnology: Pharmaceutical Preparations
Board MeetingOct 19, 2026, 04:56 PM

Supernus Pharmaceuticals Q3 2026 Earnings Call Scheduled for Oct 29

AI Summary

Supernus Pharmaceuticals, Inc. announced it will release its third quarter 2026 financial and business results on October 29, 2026, after market close. The company will host a conference call and webcast on the same day at 4:30 p.m. ET to discuss the results. A replay of the webcast will be available on the company's investor relations website.

Key Highlights

  • Supernus Pharmaceuticals will report Q3 2026 financial and business results after market close on October 29, 2026.
  • A conference call and webcast to discuss Q3 2026 results is scheduled for October 29, 2026, at 4:30 p.m. ET.
  • The webcast will be available on the Company's Investor Relations website for 60 days following the live call.
View SEC Filing
SUPN
Biotechnology: Pharmaceutical Preparations
SUPERNUS PHARMACEUTICALS, INC.

Price Impact

More from SUPN

MergerOct 15, 4:16 PM

Supernus Pharmaceuticals Stockholders Approve Merger With Indivior

MergerAug 3, 8:38 AM

Supernus and Indivior Announce Proposed Merger of Equals

Quarterly ResultAug 3, 7:02 AM

Supernus Q2 Net Loss $(58.37)M; Revenue $219.06M

More in Board Meeting

GLNG13h ago

Golar LNG to Announce Q3 2026 Results on November 18

RACE3d ago, 9:41 AM

Ferrari Q3 2026 Earnings Call Scheduled for November 3

ZTO3d ago, 6:16 AM

ZTO Express Schedules Q3 2026 Earnings Release and Conference Call